Document Detail


Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.
MedLine Citation:
PMID:  19441924     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Severe acute respiratory syndrome (SARS) coronavirus emerged from an animal reservoir in 2002 and has the potential to reemerge, as shown by the occurrence of non-laboratory-associated new cases in the winter of 2003. In the absence of a vaccine, broad spectrum anticoronaviral medications are needed. OBJECTIVE: Anticoronavirals targeting viral entry were reviewed in part I. Here we review anticoronaviral therapies directed against the intracellular life cycle, with an emphasis on allowed patents and pending patents. METHOD: The published literature, in particular, patent publications is searched for relevant documents. The information is organized and critiqued. RESULTS/CONCLUSION: Many promising anticoronaviral strategies are identified. Monoclonal antibodies, protease inhibitors, interferon-based drugs and nucleic-acid based antivirals are most advanced, each having its own advantages and disadvantages. A multi-pronged approach, keeping all venues open, is advocated.
Authors:
Tommy R Tong
Related Documents :
20642314 - Summary report of journal operations, 2009.
22448114 - Review of australasian spider flies (diptera, acroceridae) with a revision of panops la...
8727104 - Setting reactions in dental amalgam. part 1. phases and microstructures between one hou...
1501184 - Effects of environmental factors on maxillofacial elastomers: part i--literature review.
10707364 - Histological features of resolving acute, non-complicated phlegmonous appendicitis.
16877994 - The congenital intrahepatic arterioportal fistula syndrome: elucidation and proposed cl...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on therapeutic patents     Volume:  19     ISSN:  1744-7674     ISO Abbreviation:  Expert Opin Ther Pat     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-05-15     Completed Date:  2009-07-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9516419     Medline TA:  Expert Opin Ther Pat     Country:  England    
Other Details:
Languages:  eng     Pagination:  415-31     Citation Subset:  IM    
Affiliation:
Jack D Weiler Hospital, Montefiore Medical Center, Department of Pathology, 1825 Eastchester Road, Bronx, NY 10461, USA. ttong@montefiore.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antiviral Agents / pharmacology*
Coronavirus / drug effects*
Coronavirus Infections / drug therapy*,  virology
Humans
Patents as Topic
SARS Virus / drug effects
Severe Acute Respiratory Syndrome / drug therapy,  virology
Chemical
Reg. No./Substance:
0/Antiviral Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sirtuin activators.
Next Document:  Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection...